Kiniksa Pharmaceuticals Competitors and Similar CompaniesClear all

Kiniksa Pharmaceuticals's competitors and similar companies include Cipla.
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals focuses on the discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need.
Cipla
Cipla
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Founding Date
Founding Date
2015
Founding Date
1935
Type
Type
Public
Type
Public
Tags
Locations
Locations
Lexington, US HQ
Hamilton, BM
London, GB
San Diego, US
Locations
Mumbai, IN HQ
Melbourne, AU
Antwerpen, BE
São Paulo, BR
São Paulo, BR
Unterhaching, DE
Nairobi, KE
see more
Employees
Employees
220437% increase
Employees
27,764

Financial

Revenue (est.)
Revenue (est.)
$677.6m (FY, 2025)
Revenue (est.)
₹277.1b (FY, 2026)
Cost of goods
Cost of goods
$77.7m (FY, 2025)
Cost of goods
₹95.5b (FY, 2026)
Gross profit
Gross profit
$599.9m (FY, 2025)
Gross profit
₹195b (FY, 2026)
Net income
Net income
$59m (FY, 2025)
Net income
₹38.7b (FY, 2026)
For sources of this data, please see the company profile

View Company Profiles

Cipla
HQ
Mumbai, IN
Employees
27,764

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.

View company